Bozzola Mauro, Bozzola Elena, Montalbano Chiara, Stamati Filomena Andreina, Ferrara Pietro, Villani Alberto
Department of Internal Medicine and Therapeutics, Unit of Pediatrics and Adolescentology, University of Pavia, Pavia, Italy.
Onlus "Il Bambino e il suo pediatra", Galliate, Italy.
Ann Pediatr Endocrinol Metab. 2018 Jun;23(2):57-61. doi: 10.6065/apem.2018.23.2.57. Epub 2018 Jun 20.
Constitutional delay of growth and puberty (CDGP) is the most common cause of delayed puberty (DP), is mainly found in males, and is characterized by short stature and delayed skeletal maturation. A family history of the subject comprising the timing of puberty in the parents and physical examination may provide clues regarding the cause of DP. Delayed onset of puberty is rarely considered a disease in either sex. In fact, DP usually represents a common normal variant in pubertal timing, with favorable outcomes for final height and future reproductive capacity. In adolescents with CDGP, a linear growth delay occurs until immediately before the start of puberty, then the growth rate rapidly increases. Bone age is often delayed. CDGP is a diagnosis of exclusion; therefore, alternative causes of DP should be considered. Functional hypogonadotropic hypogonadism may be observed in patients with transient delay in hypothalamic-pituitary-gonadal axis maturation due to associated conditions including celiac disease, inflammatory bowel diseases, kidney insufficiency, and anorexia nervosa. Permanent hypogonadotropic hypogonadism (pHH) showing low serum value of testosterone or estradiol and blunted follicle-stimulating hormones (FSH) and luteinizing hormones (LH) levels may be due to abnormalities in the central nervous system. Therefore, magnetic resonance imaging is necessary to exclude morphological abnormalities and neoplasia. Moreover, pHH may be isolated, as observed in Kallmann syndrome, or associated with other hormone deficiencies, as found in panhypopituitarism. Baseline or gonadotropin-releasing hormone pituitary stimulated gonadotropin level is not sufficient to easily differentiate CDGP from pHH. Low serum testosterone in male patients and low estradiol values in female patients, associated with high serum FSH and LH levels, suggest a diagnosis of hypergonadotropic hypogonadism. A genetic analysis can reveal a chromosomal abnormality (e.g., Turner syndrome or Klinefelter syndrome). In cases where the adolescent with CDGP is experiencing psychological difficulties, treatment should be recommended.
体质性生长和青春期延迟(CDGP)是青春期延迟(DP)最常见的原因,主要见于男性,其特征为身材矮小和骨骼成熟延迟。该患者的家族史,包括父母青春期的时间以及体格检查,可能为DP的病因提供线索。青春期启动延迟在男女中很少被视为一种疾病。事实上,DP通常代表青春期时间的一种常见正常变异,对最终身高和未来生殖能力有良好的结果。在患有CDGP的青少年中,线性生长延迟会一直持续到青春期开始前,然后生长速度迅速增加。骨龄通常延迟。CDGP是一种排除性诊断;因此,应考虑DP的其他病因。由于包括乳糜泻、炎症性肠病、肾功能不全和神经性厌食症等相关疾病导致下丘脑 - 垂体 - 性腺轴成熟暂时延迟的患者,可能会观察到功能性低促性腺激素性性腺功能减退。永久性低促性腺激素性性腺功能减退(pHH)表现为血清睾酮或雌二醇值低以及促卵泡生成素(FSH)和促黄体生成素(LH)水平降低,可能是由于中枢神经系统异常所致。因此,需要进行磁共振成像以排除形态学异常和肿瘤。此外,pHH可能是孤立的,如在卡尔曼综合征中所见,或与其他激素缺乏相关,如在全垂体功能减退中所见。基线或促性腺激素释放激素垂体刺激的促性腺激素水平不足以轻易区分CDGP和pHH。男性患者血清睾酮低和女性患者血清雌二醇值低,同时伴有血清FSH和LH水平高,提示诊断为高促性腺激素性性腺功能减退。基因分析可揭示染色体异常(如特纳综合征或克氏综合征)。对于患有CDGP且正在经历心理困难的青少年病例,应建议进行治疗。